US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist
  • 48.200
  • +1.760+3.79%
Close Jan 2 16:00 ET
  • 48.780
  • +0.580+1.20%
Post 20:01 ET
3.94BMarket Cap-24.10P/E (TTM)

About Verona Pharma Company

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.

Company Profile

SymbolVRNA
Company NameVerona Pharma
Listing DateApr 27, 2017
Issue Price13.50
Founded2005
CEODr. David Zaccardelli, Pharm.D.
MarketNASDAQ
Employees79
Securities TypeDR
ADS Ratio1.0 : 8.0
Fiscal Year Ends12-31
Address3 More London Riverside
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeSE1 2RE
Phone44-203-283-4200
Websitehttp://www.veronapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David Zaccardelli, Pharm.D.
  • Executive Director,Chief Executive Officer and President
  • --
  • Piers John Morgan
  • Executive Director,Chief Financial Officer
  • --
  • Professor Dr. David Raymond Ebsworth, PhD
  • Non-Executive Director,Chairman
  • --
  • Vikas Sinha
  • Non-Executive Director
  • --
  • Sven Anders Ernst Uddo Ullman
  • Non-Executive Director
  • --
  • Michael Austwick
  • Non-Executive Director
  • --
  • Dr. Martin William Edwards, M.D.
  • Non-Executive Director
  • --
  • Christina M. Ackermann
  • Non-Executive Director
  • --
  • Lisa Deschamps
  • Non-Executive Director
  • --
  • James Brady
  • Non-Executive Director
  • --
  • Dr. Mahendra Gopaldas Shah, PhD
  • Non-Executive Director
  • --
  • Dr. Kenneth Thomas Cunningham
  • Non-Executive Director
  • --
  • Ben Harber
  • Company Secretary
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data